Announced Mon, 22 Jun · 20:55 IST
Novelix confirms it is not a Large Corporate for FY 2025-26
Compliance View source PDF
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-3.2%1-day move
₹79.61
prior close
—
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
————-3.2+0.5-3.3-3.4-2.0-2.1-10.8-14.3——
Up moveDown movePending
AI summary
Novelix Pharmaceuticals filed an initial disclosure under SEBI's Large Corporate framework, confirming it does not qualify as a Large Corporate for FY 2025-26. The company reported zero outstanding borrowings as on both April 1, 2024 and March 31, 2025, placing it well below the threshold. No credit rating was assigned. The company is formerly known as Trimurthi Limited.
Likely market impact
Routine compliance filing with no material impact on shareholders. Zero borrowings mean no mandatory borrowing or fine obligations under the framework.